Table 4 Significant untargeted metabolites in the cohorts (NP vs. RP).

From: Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes

 

PROLONG

DIALONG

Metabolite

ba

bb

p valuea

p valueb

ba

bb

p valuea

p valueb

Serine1

0.2

0.1

0.01

ns

0.1

0.1

ns

ns

Phenylalanine2

0.3

0.3

0.01

0.03

− 0.2

− 0.1

ns

ns

Carnitine C42

− 0.3

− 0.3

ns

ns

− 0.5

− 0.4

2.4e−03

9.1e−03

Carnitine C52

− 0.1

− 0.1

ns

ns

− 0.6

− 0.6

6.1e−03

0.01

Erythritol1

− 0.6

− 0.5

4.3e−03

0.03

LPE C20:42

− 0.7

− 0.6

9.7e−03

0.03

Pyroglutamate1

0

0

ns

ns

− 0.3

− 0.3

0.01

0.03

Myo-inositol1

− 0.1

− 0.1

ns

ns

− 0.4

− 0.3

0.02

ns

Glutamate1

− 0.2

0

ns

ns

− 0.7

− 0.6

0.02

ns

Hydroxyproline1

− 0.2

− 0.1

ns

ns

− 0.5

− 0.4

0.02

0.05

Cystine3,1

− 0.1

− 0.1

ns

ns

− 0.6

− 0.5

0.02

0.03

Ornithine3,1

− 0.1

− 0.1

ns

ns

− 0.5

− 0.4

0.02

ns

Hippuric acid2

− 0.6

− 0.5

0.02

ns

Carnitine2

− 0.1

− 0.1

0.03

ns

Cystine4,1

− 0.2

− 0.2

ns

ns

− 0.8

− 0.8

0.03

0.05

Creatinine1

− 0.1

− 0.1

ns

ns

− 0.5

− 0.4

0.03

ns

  1. Data were winsorized before analyses, and statistical tests performed on log2-transformed data.
  2. ns non-significant (p > 0.05).
  3. NP non-progressors, RP rapid progressors.
  4. nNP = 226, nRP = 45 for PROLONG, 1nNP = 39, nRP = 30: 2nNP = 40, nRP = 30 for DIALONG.
  5. Linear regression models: Pa (adjusted for sex, age), Pb (adjusted for sex, age, HbA1c), both models are adjusted for center/storage for PROLONG, b for effect size of binary group coefficient.
  6. 1GC-MS, 2UHPLC.